blood was used. Trypanosoma copemani was observed by microscopy in all human blood 29 cultures from day 5 to day 19 post inoculation (PI). The mechanism for normal human serum 30 (NHS) resistance in T. copemani is not known. The results of this study show that at least one 31 native Australian trypanosome species may have the potential to be infective for humans. 32
Introduction 36 37
Only a few trypanosome species are known to cause disease in mammals. These include 38 the etiological agents of animal trypanosomiasis (T. congolense, T. vivax, T. brucei brucei, and 39
T. evansi) and human African trypanosomiasis (T. b. rhodesiense and T. b. gambiense) as well as 40
T. cruzi, which causes Chagas's disease in the Americas (Hoare 1972). Trypanosoma rangeli has 41 also been detected in humans but it is not considered to be pathogenic (Stevens and Brisse 42 2004). Trypanosoma rangeli and T. cruzi share a large number of vertebrate reservoirs including 43 animals in five orders: Edentata, Marsupialia, Carnivora, Rodentia and Primates (Guhl and 44 Vallejo 2003) . 45 Trypanosoma brucei rhodesiense and T. b. gambiense are resistant to the cytotoxic action 46 of normal human serum because they are resistant to the trypanosome lytic factors (TLFs) that 47 approximately 5 millilitres (mL) of blood was collected by venepuncture of the lateral caudal 85 vein. Fifty microliters (μL) of blood were used for the BIIT test. The remainder of the blood was 86 added to commercial blood storage tubes containing ethylene diamine tetra-acetic acid (EDTA) 87 (Sarstedt, Australia) and stored at 4°C for a maximum of 14 days. Thin-blood smears were 88 prepared from 10µL of blood and stained with Modified Wright's stain using an automated slide 89 stainer (Hematek, Bayer). The blood smears were examined at 200 magnification and the 90 number of trypanosomes counted using a haemocytometer to determine the numbers of 91 trypanosomes The BIIT assay was performed in triplicate using serum freshly prepared from the blood 115 of five healthy human volunteers as the test samples (labelled HA, HB, HC, HD and HE) and 116 from horse blood as the control samples (labelled H0A, H0B and H0C). On day 14 when high numbers of motile trypanosomes were observed in HuMSEM, 100 132 μL volumes of the culture (approx. 7.5 x 10 7 organisms) were transferred into 1 mL of 133 mL of ICN penicillin and 10000MCG / mL of streptomycin. Cultures were incubated at 37ºC 135 with 5% CO 2 to mimic mammalian conditions and determine survival of T. copemani in liquid 136 culture. 137 138
Statistical analysis 139
The relative rate of replication of T. copemani in HuMSEM and HoMSEM after the BIIT 140 was assessed by performing triplicate counts on three human cultures (HA, HB, HC) and 1 horse 141 culture (H0C) at several time points after inoculation using a hemocytometer counting chamber. 142
Half of the minimum level of detection (300) was added to each of the triplicate counts of T. The identity of the trypanosome infecting quokka 2088 was confirmed as T. copemani 165 (genotype B) using sequence analysis of both the 18S rRNA and GAPDH genes before and after 166 the BIIT test. The 18S rRNA (1439bp) and GAPDH (841bp) gene sequences of the quokka 167 trypanosome isolate were found to be 100% identical to reference T. copemani sequences both 168 before and after the BIIT challenge, and therefore were deposited in the GenBank database 169 under the accession numbers (18S rRNA) HQ267094 and (GAPDH) HQ267095. 170 171
Blood Incubation Infectivity Test (BIIT) 172 173
Trypanosoma copemani isolated from quokka 2088 multiplied successfully in MSEM 174 containing either human or horse blood, after undergoing the BIIT. There was no significant 175 difference in the time to initiation of exponential growth in cultures containing human blood or 176 horse blood and trypanosomes were detected in all cultures by day 5. Plots of the log-177 transformed counts of T. copemani in cultures containing serum from 3 humans and 1 horse are 178 presented (Figure 2 ). Motile T. copemani was also observed in both the control HuMSEM and 179
HoMSEM inoculated with blood taken directly from the quokka. Unfortunately complete growth 180 curves for T. copemani directly inoculated into HuMSEM and HoMSEM from infected blood 181
were not possible due to the delayed detection of trypanosomes in the first 9 days. Numbers of 182 trypanosomes / mL were however measured at several time points from day 10 (Figure 3) with T.copemani shown to multiply at a slightly faster rate in HuMSEM at days 10, 12 and 14 184 compared to the growth rate of T. copemani in HoMSEM. On day 17, the numbers of 185 trypanosomes in HuMSEM dropped compared to that detected in HoMSEM (Figure 3) . 186
The first trypanosome life-cycle stages to be detected in both HuMSEM and HoMSEM 187 post-BIIT were slender, rapidly moving trypomastigotes and thin epimastigotes (Figure 4a 
